UK Vision Strategy consultation deadline

Article

The UK Vision Strategy consultation is due to close on 16 November 2012.

The UK Vision Strategy consultation is due to close on 16 November 2012.

Led by VISION 2020, the UK Vision Strategy is the chance to share views and ideas on the future direction of the initiative, as well as the Royal National Institute of Blind People (RNIB).

Anita Lightstone, UK Vision Strategy Programme Director and Interim Chief Operating Officer of VISION 2020 UK, commented, "It is vital that we obtain a wide cross section of views from the sector to help shape the strategy and ensure that we are moving in the right direction. This is a great opportunity for healthcare practitioners, support services, and those living with sight loss to have their say and advise us on how we can best meet their changing needs.''

Please click here for more information on how to participate in the UK Vision Strategy Consultation. Additionally, to share your ideas with the RNIB Group please click here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.